Today

Agents

Chat

Arena

Discover

More

App

Stoke Therapeutics to present at Canaccord Genuity Annual Growth Conference - STOK News | Rallies

Stoke Therapeutics to present at Canaccord Genuity Annual Growth Conference

STOK•2026-08-05

Conference presentation details

Stoke Therapeutics will present at the Canaccord Genuity 46th Annual Growth Conference on Aug. 12, 2026 at 11:00 a.m. ET.

CEO Ian F. Smith will present alongside Chief Patient Officer Jason Hoitt.

Related News

Teradata Corporation <TDC.N>: UBS Raises Target Price to $36 From $34

TDC•2026-08-05

Booking Holdings Inc. <BKNG.O>: B. Riley raises target price to $274 from $264

BKNG•2026-08-05

Leidos Holdings, Inc. <LDOS.N>: UBS raises target price to $138 from $124

•

2026-08-05

e& UAE deploys Ciena optical, software solutions for high-capacity DWDM network buildout

CIEN•2026-08-05

Revolve Group Inc <RVLV.N>: UBS raises target price to $29 from $28

RVLV•2026-08-05